 DEERFIELD, Ill., May 11, 2021 GLOBE NEWSWIRE -- Surgalign Holdings, Inc. NASDAQ: SRGA, a global medical technology company focused on elevating the standard of care through the evolution of digital surgery, today announced that it has granted equity awards to five employees, none of whom are executive officers, as an inducement for them to accept employment with Surgalign, and representing the right to purchase or receive, in the aggregate, up to 467,404 shares of Surgalign common stock. The awards were granted on May 7, 2021 under the Surgalign Holdings, Inc. 2021 Inducement Plan, and include a stock option award granted to Marc Mackey relating to 202,971 shares of Surgalign common stock at an exercise price of 1.73 per share and a restricted stock unit award granted to Mr. Mackey relating to 107,659 shares of Surgalign common stock. The remaining inducement awards were granted as restricted stock unit awards. One-fourth of the stock option award vests on the first anniversary of the date of grant, and 148th of the award vests on each subsequent monthly anniversary of the date of grant, such that the award will be fully vested on the fourth anniversary of the date of grant, subject to continued employment through the applicable vesting date. One-third of the restricted stock units vest on the first anniversary of the date of grant, and one-eighth of the remaining restricted stock units vest on each subsequent quarterly anniversary of the date of grant, such that the award will be fully vested on the third anniversary of the date of grant, subject to continued employment through the applicable vesting date. 